Individual and Familial Susceptibility to MPTP in a Common Marmoset Model for Parkinson's Disease

Conclusion: Our findings show that low-dose MPTP treatment in marmosets represents a clinically relevant PD model, with a window of opportunity to examine the onset of the disease, allowing the detection of individual variability in disease susceptibility, which may be of relevance for the diagnosis and treatment of PD in humans.Neurodegener Dis
Source: Neurodegenerative Diseases - Category: Neurology Source Type: research